The Growing Evidence for Psilocybin-Facilitated Smoking Cessation
Comments from Matthew Johnson of Johns Hopkins provide an update on this research.
Comments from Matthew Johnson of Johns Hopkins provide an update on this research.
Three clinical trials are underway to find out if these psychedelic compounds can provide relief for patients.
Understanding the pharmacology of magic mushrooms is not just about tryptamines anymore.
Surprisingly, 4-HO-TMT has binding affinity similar to psilocin at 5-HT2A.
These creatures have more in common with humans than one might suspect.
Understanding this is more important than ever in psychedelic research because scientists think DMT may be an endogenous neurotransmitter.
Psychedelic Science Review Editor Barb Bauer conducts a review of some landmark studies.
The research will use cutting-edge technology to attempt to remove undesirable side-effects from drugs targeting GPCRs, including the serotonin receptors where psychedelics act.
Researchers are uncovering reasons to think there’s more to DMT than just hallucinations.
This phenomenon plays an important role in psychedelic drug research and development.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.